Velocity Clinical Research

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Obesity3 trials

Phase

• Phase 22 trials
• Phase 11 trial

Status

• Completed3 trials

Lead sponsor

• Regor Pharmaceuticals Inc.2 trials
• Corbus Pharmaceuticals Inc.1 trial

Closed trials

• Completed

  A 2-part, Phase 1b Clinical Study Designed to Evaluate the Safety, PK, and Efficacy of CRB-913 in Participants With Obesity

  NCT07310901· Phase 1· Corbus Pharmaceuticals Inc.· Source

• Completed

  Study of Once-Daily Oral RGT001-075 Compared With Placebo in Adults With Obesity or Are Overweight With Weight-Related Health Conditions

  NCT06867718· Phase 2· Regor Pharmaceuticals Inc.· Source

• Completed

  A Study of RGT001-075 in Participants With Obesity or Overweight With Weight-Related Comorbidities

  NCT06277934· Phase 2· Regor Pharmaceuticals Inc.· Source